ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression — Stella

Home/Depression/

View on ClinicalTrials.gov

Recruiting

Back to Depression trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Stanford Psychiatry and Behavioral Sciences Department, Palo Alto, California

University of Illinois at Chicago, Chicago, Illinois

Key details

Phase

Safety & dosing

Sponsor

Stanford University

Enrollment target

~162 participants

Started

March 2026

Primary completion

October 2028

Age range

18 Years – 60 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.